SUSQUEHANNA INTERNATIONAL GROUP, LLP - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 68 filers reported holding TRANSLATE BIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$9,760,000
+81.1%
354,411
+8.4%
0.00%
Q1 2021$5,390,000
-66.4%
326,837
-62.4%
0.00%
-100.0%
Q4 2020$16,034,000
+212.2%
869,964
+130.6%
0.00%
Q3 2020$5,135,000
-7.1%
377,338
+22.3%
0.00%
-100.0%
Q2 2020$5,528,000
+3585.3%
308,475
+1955.1%
0.00%
Q1 2020$150,000
+4.2%
15,010
+3.0%
0.00%
Q3 2019$144,000
-51.0%
14,576
-37.4%
0.00%
Q2 2019$294,00023,2720.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2019
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders